Journal
NEURON
Volume 89, Issue 6, Pages 1208-1222Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2016.01.042
Keywords
-
Categories
Funding
- NIH [NS076503, MH103339, MH105972, MH106934]
- USUHS
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) [HI14C2461]
- Kavli Foundation
- James S. McDonnell Foundation
- Ruth Kirschstein National Research Service Award (NRSA)
- China Scholarship Council
Ask authors/readers for more resources
Trisomy 21, or Down syndrome (DS), is the most common genetic cause of developmental delay and intellectual disability. To gain insight into the underlying molecular and cellular pathogenesis, we conducted a multi-region transcriptome analysis of DS and euploid control brains spanning from mid-fetal development to adulthood. We found genome-wide alterations in the expression of a large number of genes, many of which exhibited temporal and spatial specificity and were associated with distinct biological processes. In particular, we uncovered co-dysregulation of genes associated with oligodendrocyte differentiation and myelination that were validated via cross-species comparison to Ts65Dn trisomy mice. Furthermore, we show that hypomyelination present in Ts65Dn mice is in part due to cell-autonomous effects of trisomy on oligodendrocyte differentiation and results in slower neocortical action potential transmission. Together, these results identify defects in white matter development and function in DS, and they provide a transcriptional framework for further investigating DS neuropathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available